At CTS, we understand the impact converting to the Ortho viral marker platform has on your operations. As we get closer to our implementation date of January 11, 2021 we are committed to providing you information as it becomes available.
Package inserts for the new assays are now available. You can review them on the Communications page by clicking this link: Communications,
Through communications with our clients, CTS is aware of the current national blood shortage. We rea...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm. Th...
The FDA Guidance ZIKV video for the webinar held on 08/15/18 has been posted in the Wh...
On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to ...
On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm thi...